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We have investigated the role of ADP-~bosylation factor (ARF) in regulated exocytosis in di~tonin-~~eabil~ed adrenal chroma& cells by 
the use of a synthetic peptide, hARFl(Z-17), based on the N-terminus of the protein hARF1(2-17) inhibited &+-dependent but not basal 
exocytosis, whereas equimoiar leveis of other synthetic peptides were ineffective. The inhibitory effect of hARFl(Z-17) was dose-dependent and 
half-maximal at 12 ,uM. GTPyS-induced secretion in the presence of non-stimulatory CA*+ concentrations was also inhibited by hARF1(2-17). 
These results point to a hitherto unsuspected role for ARF in regulated exocytosis, and the potency of the hARF1(2-17) peptide suggests that ARF 
is essential for exocytosis in bovine adrenal chromafhn cells, 
Exocytosis; Calcium; ADP-ribosylation factor; GTP-binding protein; Chromafin cell 
1. I~ROD~CTION 
Regulated exocytotic fusion of secretory vesicles with 
the plasma membrane is triggered by Ca*+ in many cell 
types [ 1,2] but the mechanisms involved are not known. 
The use of permeabilised cells has begun to identify the 
proteins that may be involved in exocytosis [2] but more 
detailed characterisation has been achieved for the pro- 
teins involved in various other vesicular transport steps 
[3]. Certain key proteins appear to function in many 
intracellular membrane fusion events and may also be 
involved in regulated exocytosis [4]. GTP-binding pro- 
teins appear to control all vesicular transport steps in 
the exocytic and endocytic pathways [5-71. ADP-ri- 
bosylation factor (ARF) [8], a monomeric GTP-binding 
protein, is a component of the non-clathrin coats of 
Golgi transport vesicles [9], regulates coat assembly [lo] 
and has been implicated in multiple vesicle transport/ 
fusion steps [ll-141. The N-terminus of ARF is essen- 
tial for its function and a synthetic N-terminal ARF 
peptide inhibits ARF function, endoplasmic reticulum 
(ER)-to- Golgi transport, intra-Golgi transport and en- 
docytic vesicle fusion [IO-I 31. We have examined the 
effect of synthetic hARFl(2-17) and found that it inhib- 
its Ca*‘- and GTP~S-de~ndent secretion from permea- 
bilised adrenal chroma~n cells whereas other peptides 
are ineffective. These results implicate ARF as a key 
component of the regulated exocytotic machinery and 
emphasise the similarity of the mechanisms involved in 
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the vesicular fusion events throughout the secretory 
pathway. 
2. MATERIALS AND METHODS 
2.1. Materials 
High-purity digitonin was obtained from Novabiochem (Notting- 
ham, UK). Fetal calf serum and Dulbecco’s modified Eagle’s medium 
with 25 mM HEPES were obtained from Gibco (Paisley, UK). GTPyS 
was obtained from Boehringer-Mannheim (Lewes, UK). The 
rab3AL(3347) peptide was synthesised in the Department of Bio- 
chemistry, University of Liverpool. hARF1(2-17), sec4(1-15), cal(l- 
15) and SynA(217-231) peptides were synthesized by Multiple Peptide 
Systems (San Diego, CA, USA), character&d by mass spectrometry 
and purified by reverse-phase HPLC. All other chemicals were from 
Sigma (Poole, UK). 
2.2. Isolation and culture 0fchromafJ cells 
Chromaffin cells were isolated from bovine adrenal medulla by 
enzymic digestion [15], washed in Ca*+-free Kreb’s-Ringer buffer, (145 
mM NaCl, 5 mM KCl, 1.3 mM MgCl,, 1.2 mM NaHzPO,, 10 mM 
glucose and 20 mM HEPES at pH 7.4), resuspended in culture me- 
dium (Dulbecco’s modified Eagle’s medium with 25 mM HEPES, 10% 
fetal calf serum, 8 PM fluorodeoxyuridine, 50 ,ug/ml gentamycin, 10 
PM cytosine arabinofuranoside, 2.5 &ml amphotericin B, 25 U/ml 
penicillin, 25 pg/ml streptomycin), plated in 24-well trays at a density 
of 1 x lo6 cells per well, and maintained in culture for 3-5 days before 
use 1151. 
2.3. Cell permeabil~atio~ and assay o~catecho~~i~e secretion 
After initial washing of cells in Ca”-free Kreb’s-Ringer buffer, the 
protocol was in two stages unless indicated otherwise. (1) Cells were 
permeabilized with 300 ,ul of buffer A (139 mM potassium glutamate, 
2 mM ATP, 2 mM MgCI,, 5 mM EGTA, 20 mM PIPES at pH 6.5) 
containing 20 PM digitonin for 10 min. (2) Cells were stimulated with 
300 ~1 of buffer A containing the indicated calculated free Ca2’ con- 
centrations for 20 mm. Synthetic peptides were routinely present in 
both stages unless indicated otherwise. After stage 2, the buffer was 
removed, centrifuged at 16,000 x g for 2 min and aliquots taken for 
assay of released endogenous catecholamine. Total catecholamine 
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content of the c&Ifs was determined after rekwa of catecbo~mines 
with I% Triton X-100. Catechotamine secfetion was calculated as a 
pevzentage of total cellular catecholamine. All experiments were per- 
formed at 22-25°C. 
3. RESULTS 
We examined the effect of a rauge of peptides on 
Caz”-dependent secretion of catecholamirre from dig- 
itu~in-~~eab~~s~ adrenal chr5maB.n c&s. These 
peptides (Fig. 1) correspond to the putative eB%ctor 
domain of rab3 (rab~A~~~7~ [IQ, the essential N- 
teeing domain of human ARFl (~RF~(2-~7~ f 1 t]fl 
the N-tctinus of annexin 11 (cal(l-15)>, and yeast set 
4 fseo4(1-15)), and a cytoplasm& sequence af the synap- 
tic plasma membrane proteins the syntaxins (synA(217- 
231) [17] which has homology to related proteins in- 
volved in vesicular traffic includiag the yeast protein 
SEDS [18]. Although all five peptides were used at a 
concentration of 100 PM, only hARFf_(2-17) inhibited 
10 FM Ca”-induced secretion (Fig. 21, The inhibitory 
control rab3AL hARF1 cat SW4 SynA 
(33-471 12-17) (l-11) (l-15) (217-231) 
Fig, 2. Effect of various synthetic peptides on C$‘-dependent secre- 
tion from permeabilised adrenal chromtia cdls. Cells were permea- 
bilised with digitonin for 10 min in the absence or presence of 100,uM 
peptide prior to stimulation with 10 pM Ca’” in the a&ewe or pres- 
em% of peptide. cat~holamine sefease over 20 tin was expm8ed as 
a percentage rtf tti d&ar ~~~h~~~~~. I&a shown axe 
effect of hARF t (2-f 7) was reprodu~~b~e and, in a series 
of e~pe~ments, this peptide ~nhib~~ secretion by 
83.2 -t- 2S%(n = 9). The rab3At peptide provides a 
good control for the examination of the effects of 
hARFl(Z-17). The two peptides contain similar num- 
bers of hydrophobic residues and have the same charge 
density (three basic and one acidic ammo acids) and 
distribution of charged residues, but rab3AL(33-47) 
had no effect on secretion in our experiments. 
The dose-response for ~n~b~tjon of secretion by 
~RF~(2-17~ is shown in Fig. 3. This peptide had no 
effect on basal (Cafe-~de~ndent~ secretion at doses up 
to 50 ,&.%, but inhibited 10 FM Ca’“-induced secretion. 
Half-maximal inhibition occurred at 12 ,BM and the 
effect saturated at around 50 PM. The peptide was 
therefore effective at similar concentrations to those 
that inhibit ER-to-Go&j and in&a-Go@ transport 
[l 1,123, endosome-endosome fusion [13] and /I-COP 
binding to Golgi membranes [lo]. At higher doses 
(> 100~&I) hARFl(2-17) began to stimulate low levels 
of Ca”*-independent release of ~atech~~~~~e~ and this 
may r&ect a m~rnbr~ne-~r~b~n~ effect of high doses 
of the peptide. The ~nh~b~to~ eff&t of l&RF1 (2-l 7) ore 
vesicular fusion is b&eved to be due to tight binding of 
the peptide to a putative ARF receptor which prevents 
recruitment of cytosolic ARF to membranes [XI-131. 
The inhibitary action of hARF1(2--17) on ER-to-Golgi 
transport was found to be irreversible [12] and we also 
found that the hARF1(2-27) inhibition could not be 
reversed by subsequently washing the cells for 15 min 
prior to stimulation. Again, as reported for ER-to- 
Golgi transport [12], we found that the inhibitory e&et 
of hARFl(2-17) was partially antagomsed when the 
cti-I& were pm-incubated with the peptide in the presence 
of brain cytosol. fn the ex~r~en~ shown, hARFi(2- 
17) was included during ~~eab~~~sat~u~ b t in other 
experiments it was found to be equally effective when 
incorporated in a post-permeabilisatioa step prior to 
stimulation, ruling out an artefact due to interference 
with permeabilisation. The peptide inhibition of secre- 
tion was most marked when the cells were pm-incubated 
with the peptide prior to stimulation with Ca’+, and 
peptide addition with the Ca2+ stimulus reduced secre- 
tion by only 42%, suggesting that hARF1(2-17) gener- 
ated a time~de~ndent Mock of exocytosis. 
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Fig. 3. Dose-dependency of the inhibitory effect of hARF1(2-17). 
Cells were permeabilised for 10 min in the presence of varying concen- 
trations of hARF1(2-17) prior to incubation with 0 or 10pM free Ca2’ 
in the presence of hARF1(2-27). Catecholamine released over 20 min 
was expressed as a percentage of total cellular catecholamine. Data 
shown are means (n = 6); the S.E.M. was smaller than the symbols and 
is not shown. 
GTPyS [ 19,201, but at non-stimulatory Ca*+ concentra- 
tions (300 nM or less) non-hydrolysable GTP analogues 
stimulate exocytosis [21,22]. As shown in Fig. 4, 
hARF1(2-17) inhibited not only Ca*+-induced but also 
GTPyS-induced exocytosis in chromaffin cells, indicat- 
ing that the peptide inhibits a step required by both 
types of stimuli. 
4. DISCUSSION 
N-Terminal ARF peptides have proved to be potent 
inhibitors of ARF function [lO-131. The specific inhibi- 
tion of regulated exocytosis in chromaffin cells by 
hARF1(2-17) implicates ARF as a key part of the ex- 
ocytotic machinery. A small component of Ca*‘-de- 
pendent exocytosis was uninhibited by the peptide. The 
magnitude of this component was similar to that of the 
cytosol-independent component remaining after pro- 
longed permeabilisation, and this may represent the 
population of already docked or ‘primed’ secretory ves- 
icles that exists in chromaffin cells [2,23,24]. Data from 
work on the effects of GTP analogues on exocytosis in 
the squid giant synapse has suggested a role for monom- 
eric GTP-binding proteins in vesicle docking prior to 
Ca*+-activated neurotransmitter release [7]. Recent 
work has established that ARF proteins are important 
mediators of vesicular transport, and the results have 
been interpreted on the basis of a putative role in trans- 
port vesicle coat assembly/disassembly [9,11,25]. This is 
difficult to reconcile with the present data (since chro- 
maffin granules are not coated) and with the observa- 
tions on ARF involvement in endosome-endosome fu- 
sion [13]. The drug, brefeldin A, inhibits various steps 
in the secretory pathway by effect on coat assembly due 
to an inhibition of guanine nucleotide exchange on 
ARF [26,27]. We found no effect of pre-incubation with 
brefeldin A on Ca*+-dependent secretion in permeabil- 
ised chromaffin cells nor did it influence the effects of 
GTPyS or hARF1(2-17) (data not shown). Therefore, 
it seems more likely that ARF proteins control mem- 
brane targeting and/or fusion, possibly by promoting 
the assembly of a multi-subunit complex required at the 
fusion site. This is an attractive hypothesis ince numer- 
ous cytosolic and membrane proteins have been impli- 
cated in fusion in the secretory pathway, and these pre- 
sumably interact to form a fusion machine [2,3]. 
The rab family of monomeric GTP-binding proteins 
also appear to be involved at all stages of the secretory 
pathway [28]. Synthetic peptides based on the putative 
effector domain of rab proteins, such as rab3AL (33- 
47), inhibit ER-to-Golgi and intra-Golgi transport [15] 
and can stimulate exocytosis [29-311. Recent work has 
shown that rab3AL (3347) had no effect on Ca*‘-de- 
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Fig. 4. Effect of hARF1(2-17) on GTPyS- and Ca*+-induced secre- 
tion. Cells were permeabilised for 10 min in buffer A containing 20pM 
digitonin in the presence or absence of 100,uM hARF1(2-17) and in 
the presence or absence of 100 PM GTP[S] prior to stimulation with 
Buffer A containing 300nM free Ca2’, 300nM free Ca2+ plus 100 PM 
GTPyS or 10 pM free Ca2’ in the presence or absence of 100 pM 
hARF1(2-17). Catecholamine released over a 20 min period was ex- 
pressed as a percentage of total cellular catecholamine. Data shown 
are means + S.E.M. (n = 6). 
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pendent exocytosis in pituitary cells, consistent with 
data here, but that a longer peptide, rab3AL (30-47), 
potently inhibited secretion [32]. Thus it appears that 
both ARF and rab proteins are required for regulated 
exocytosis. These findings and other recent discoveries 
[4,33] suggest hat the targeting and fusion machinery 
in regulated exocytosis involves members of the same 
protein families that act in other intracellular membrane 
fusion events. 
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